TNFR2 and IL-33 identified as targets in Dupuytren's disease

By Claire Quang | Jan 31, 2020 | 11:37 PM GMT

DISEASE CATEGORY: Musculoskeletal

INDICATION: Dupuytren's disease

Inhibiting TNFR2 and IL-33 could treat Dupuytren's disease, which is characterized by progressive fibrosis of the palmar and digital fascia. The

Read the full 257 word article

How to gain access

Continue reading with a
two-week free trial.